Author Guidelines

Guide for Authors

General

Journal of Science and Technology Advances is self sponsored and aims to set up an academic communicating platform for Indian and scientists all over the world. The Journal invites concise reports of original research in all areas of Pharmacy both experimental and clinical, including modern, traditional and epidemiological studies including Biotechnology, from any part of the world. Review articles based primarily on authors’ own research on internationally important topics will be accepted. Short communications and letters to the editor are also welcome. Authors are requested to submit a covering letter indicating that their manuscript represents original unpublished material that has not been and will not be published elsewhere (if accepted). This restriction does not apply to results published as abstracts of communications, letters to the editor or as preliminary reports. The manuscripts must be submitted in Microsoft word (.doc, .docx) only. By submitting a manuscript the authors warrant that they have obtained permission to use any copyrighted or previously published materials.

Conflict of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Acknowledgements

Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.

Funding Acknowledgement

To comply with the guidance for Research Funders, Authors and Publishers, Journal of Science and Technology Advances additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading.

Copyright

The submission of a manuscript by authors implies that they automatically agree to assign exclusive copyright to the Journal of Science and Technology Advances if the manuscript is accepted for publication. The work should not be published elsewhere in any form without the written permission of the Journal of Science and Technology Advances. All rights of the articles published in the Journal of Science and Technology Advances are reserved. No part of this publication may be reproduced, translated or transmitted in any form or by any means (electronic, mechanical or otherwise) without permission from the Journal of Science and Technology Advances.

Please Download Copyright Form here

Ethics

Journal of Science and Technology Advances insists on ethical practices in both human and animal experiments. Evidence for approval by a local Ethics Committee must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

Authors must be careful when they reproduce text, tables or illustrations from other sources. Plagiarism will be viewed seriously. Please see instructions below on this subject. All accepted papers are subject to editorial changes.

Short communications

Short communications not exceeding two printed pages, including title, author affiliations, references and one figure or table, are acceptable for rapid publication if requested by the authors.

Letters to the editor

Criticisms or comments of less than 500 words and five references are welcome. Preference is given to letters related to articles published in the Journal of Science and Technology Advances.

Review articles

Review articles are summaries of excellent scientific research articles which deal with specific research areas of within the scope of the Journal of Science and Technology Advances. Review articles should be approximately 3000 words.

MANUSCRIPT CONTENTS

Manuscript

The manuscript should be submitted online through our website and the text should be double spaced 12 pt Times New roman and have wide margins. The manuscript should be arranged in the following order:

1) Title Page, 2) Keywords, 3) Abstract, 4) Corresponding author, 5) Introduction, 6) Materials and Methods, 7) Results, 8) Discussion, 9) Acknowledgments, 10) References, 11) Tables, 12) Figure Legends and 13) Figures. Please indicate the page of your manuscripts to facilitate reviewing.

Title page

The title page should contain, on separate lines, the title of the manuscript, a running title of no more than 40 letters, the name(s) and affiliation(s) of the author(s), and the mailing address, telephone and fax numbers, and Email address of the corresponding author. The title must be informative, specific, and concise. Serialization of articles into parts is not permitted; such articles may be submitted independently with self-sufficient titles.

Authors

All authors should have participated sufficiently in the work to take public responsibility for the content. Written approval signed by all authors should be presented with the manuscript. 12 pt Times New Roman centered, bold – author and all co-authors names in one line. The corresponding author should include an asterisk*. The affiliations are in 12 pt Times New roman centered – giving each authors’ affiliation (i.e. Department/Organization/Address/Place/Country/email). Followed by single line spacing. Author for Correspondence: 10pt Times New roman centered – giving a valid e-mail of the corresponding (main) author is a must. It should be indicated as* followed by two line spacing.

Abstract

The Abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Objective, the context and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract. 12 pt Times New roman, full justification Normal – maximum 350 words

Keywords

Provide 3–10 key words or phrases for indexing purposes, using terms from the latest US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html. If appropriate MeSH terms are not available, other suitable terms may be used.

Text

Major headings (ABSTRACT, KEYWORDS, INTRODUCTION, MATERIALS AND METHODS, RESULTS, DISCUSSION, ACKNOWLEDGEMENTS, REFERENCES) in upper case left-justified, 12 pt bold, Intermediate headings should be in italics, sentence case, left justified, 12 pt.

The text should include the following sections.

Introduction: The Introduction summarizes the rationale, provides a concise research background (not an exhaustive review) and states in one sentence the objective of the study. Do not include any results or the conclusions of the study.

Materials and Methods: The Materials and Methods provide technical information about the study. Do not describe methodological details that have been published previously. Specifications (including the manufacturer, city, and the country) should be given for the main drugs, chemicals, and instruments. Indicate the statistical methods used and identify statistical significance using superscripts (a and b) following the data (aP < 0.05, bP < 0.01).

Results: The Results are the findings, using SI units. In a sample, the number of effective digits is determined by the variation within the sample, that is, one-third of the standard deviation. Digits may be separated into groups of three by a small space.

Discussion: The Discussion deals with the interpretation of the results and their comparison with those of other studies. Do not repeat the results, do not review the literature, do not repeat textbook knowledge and do not cite references that do not have a close relationship with the present results. End with a brief conclusion linking back to the aim of the study.

Abbreviations

The use of abbreviations, except for units of measure, is discouraged. At the first appearance in the abstract and the text, abbreviations should be preceded by words for which they stand.

Tables

Tables must be concise and cited consecutively using Arabic numerals in the text (Table 1, Table 2, etc.). Each table should be typed on a separate sheet, have a short, one-line title in bold text. Tables should be as small as possible. The title of the table should clearly indicate the nature of the contents and sufficient details should be included in the footnote to facilitate interpretation without reference to the text. Symbols and abbreviations are defined immediately below the table, followed by essential descriptive material as briefly as possible, all in double-spaced text.

Figures

Figures (photographs, drawings, diagrams and charts) should be clear, easily legible and cited consecutively using Arabic numerals in the text (Figure 1, Figure 2…etc.). The goal is for figures to be comprehensible to readers in other or related disciplines, and to assist their understanding of the paper. Unnecessary figures and parts (panels) of figures should be avoided: data presented in small tables or histograms, for instance, can generally be stated briefly in the text instead. Avoid unnecessary complexity, colouring and excessive detail. Please supply figures 1.5 to 2 times the size at which they will be finally reproduced. For line work, submit black-ink drawings of professional quality. Micrographs or other glossy photographs must be of the highest quality. Use standard symbols: ○, ●, ×, □, ■, △, ▲. Freehand or typewritten lettering is unacceptable. If a figure comprises more than one glossy photograph, these should be marked A, B, C…etc. Figure legends should be marked clearly with their correspond letters. Legends should contain sufficient detail to permit figure interpretation without reference to the text. Scale markers should be indicated in the photographs. Color plates are also welcome. The choice of cover art illustration will be made by the Editor.

Lettering in figures should be in lower-case type, with the first letter capitalized and no full stop. Units should have a single space between the number and the unit, and follow SI nomenclature or the nomenclature common to a particular field. Thousands should be separated by commas (1,000). Unusual units or abbreviations are defined in the legend. The illustration or figure must be prepared at a minimum of 350 dpi at the final publication size. Lower resolution will result in pixilation and poor quality images. These should be submitted as JPEG, TIFF or PPT files.

Table and Figure captions

Figure and table captions should be included at the end of the manuscript. Figure captions/legends should include a statement at the end of each caption/legends about reproduction size (e.g. at full page width, at column width). They should be double spaced and typed in the journal format. Explanations should be brief and authors should keep in mind that captions/legends will be placed below figures.

EXAMPLES OF REFERENCES – VANCOUVER STYLE

(from Uniform Requirements for Manuscripts, www.icmje.org)

Articles in Journals

1. Standard journal article

List the first six authors followed by et al. (Note: NLM now lists up through 25 authors; if there are more than 25 authors, NLM lists the first 24, then the last author, then et al.)

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(7):284-7.

As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted.
(Note: For consistency, the option is used throughout the examples in Uniform Requirements. NLM does not use the option.)

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

More than six authors: Gillespie NC, Lewis RJ, Pearn JH, Bourke ATC, Holmes MJ, Bourke JB, et al. Ciguatera in Australia: occurrence, clinical features, pathophysiology and management. Med J Aust. 1986;145:584-90.

2. Organization as author

The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med J Aust. 1996;164:282-4.

3. No author given

Cancer in South Africa [editorial]. S Afr Med J. 1994;84:15.

4. Article not in English

(Note: NLM translates the title to English, encloses the translation in square brackets, and adds an abbreviated language designator.) Ryder TE, Haukeland EA, Solhaug JH. Bilateral infrapatellar seneruptur hostidligere frisk kvinne. Tidsskr Nor Laegeforen. 1996;116:41-2.

5. Volume with supplement

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

6. Issue with supplement

Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol. 1996;23(1 Suppl 2):89-97.

7. Volume with part

Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem. 1995;32(Pt 3):303-6.

8. Issue with part

Poole GH, Mills SM. One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z Med J. 1994;107(986 Pt 1):377-8.

9. Issue with no volume

Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop. 1995;(320):110-4.

10. No issue or volume

Browell DA, Lennard TW. Immuno-logic status of the cancer patient and the effects of blood transfusion on antitumor responses. Curr Opin Gen Surg. 1993:325-33.

11. Pagination in Roman numerals

Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction. Hematol Oncol Clin North Am. 1995 Apr;9(2):xi-xii.

12. Type of article indicated as needed

Enzensberger W, Fischer PA. Metronome in Parkinson’s disease [letter]. Lancet. 1996;347:1337. Clement J, De Bock R. Hematological complications of hantavirus nephro-pathy (HVN) [abstract]. Kidney Int. 1992;42:1285.

13. Article containing retraction

Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Ceruloplasmin gene defect associated with epilepsy in EL mice [retraction of Garey CE, Schwarzman AL, Rise ML, Seyfried TN. In: Nat Genet. 1994;6:426-31]. Nat Genet. 1995;11:104.

14. Article retracted

Liou GI, Wang M, Matragoon S. Precocious IRBP gene expression during mouse development [retracted in Invest Ophthalmol Vis Sci. 1994;35:3127]. Invest Ophthalmol Vis Sci. 1994;35:1083-8.

15. Article with published erratum

Hamlin JA, Kahn AM. Herniography in symptomatic patients following inguinal hernia repair [published erratum appears in West J Med. 1995;162:278]. West J Med. 1995;162:28-31. Books and Other Monographs (Note: Previous Vancouver style incorrectly had a comma rather than a semicolon between the publisher and the date.)

16. Personal author(s)

Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

17. Editor(s), compiler(s) as author

Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

18. Organization as author and publisher

Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992.

19. Chapter in a book

(Note: Previous Vancouver style had a colon rather than a p before pagination.) Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hyperten-sion: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995: 465-478.

20. Conference proceedings

Kimura J, Shibasaki H, editors. Recent advances in clinical neuro-physiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.

21. Conference paper

Bengtsson S, Solheim BG. Enforce-ment of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Procee-dings of the 7th World Congress on Medical Infor-matics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992: 1561-5.

22. Scientific or technical report

Issued by funding/sponsoring agency: Smith P, Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services (US), Office of Evaluation and Inspections; 1994 Oct. Report No.: HHSIGOEI69200860. Issued by performing agency: Field MJ, Tranquada RE, Feasley JC, editors. Health services research: work force and educational issues. Washington: National Academy Press; 1995. Contract No.: AHCPR282942008. Sponsored by the Agency for Health Care Policy and Research.

23. Dissertation

Kaplan SJ. Post-hospital home health care: the elderly’s access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995.

24. Patent

Larsen CE, Trip R, Johnson CR, in-ventors; Novoste Corporation, assignee. Methods for procedures re-lated to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25. Other Published Material

25. Newspaper article

Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. The Washington Post 1996 Jun 21;Sect. A:3 (col. 5).

26. Audiovisual material

HIV+/AIDS: the facts and the future [videocassette]. St. Louis (MO): Mosby-Year Book; 1995.
27. Legal material Public law: Preventive Health Amendments of 1993, Pub. L. No. 103-183, 107 Stat. 2226 (Dec. 14, 1993).

Unenacted bill: Medical Records Confidentiality Act of 1995, S. 1360, 104th Cong., 1st Sess. (1995).

Code of Federal Regulations:

Informed Consent, 42 C.F.R. Sect. 441.257 (1995). Hearing: Increased Drug Abuse: the Impact on the Nation’s Emergency Rooms: Hearings Before the Subcomm. on Human Resources and Intergovernmental Relations of the House Comm. on Government Operations, 103rd Cong., 1st Sess. (May 26, 1993).

28. Map

North Carolina. Tuberculosis rates per 100,000 population, 1990 [demo-graphic map]. Raleigh: North Carolina Dept. of Environment, Health, and Natural Resources, Div. of Epidemio-logy; 1991.

29. Book of the Bible

The Holy Bible. King James version. Grand Rapids (MI): Zondervan Publishing House; 1995. Ruth 3:1-18.

30. Dictionary and similar references

Stedman’s medical dictionary. 26th ed. Baltimore: Williams & Wilkins; 1995. Apraxia; p. 119-20.

31. Classical material

The Winter’s Tale: act 5, scene 1, lines 13-16. The complete works of William Shakespeare. London: Rex; 1973. Unpublished Material

32. In press

(Note: NLM prefers “forthcoming” because not all items will be printed.) Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med. In press 1996.

Electronic Material

33. Journal article in electronic format

Schimdt D, Lynch, J. Evaluation of the reproducibility of parallel artificial membrane permeation assays (PAMPA). Millipore Corporation; USA [Serial online] 2002 [cited in 2002]. Available from:http://www.millipore.com/techpublications/tech1/ANI728EN00

PLAGIARISM

Authors should note that copying text, tables or illustrations from any source (journal article, book, monographs, thesis, Internet/any electronic media or any other published or unpublished material) and passing it as ones own is considered plagiarism whether or not a reference to the copied portion is given. Listing the source of copied material under ‘References’ does not absolve the authors of plagiarism. If a few lines of text are to be reproduced from any source, ‘the author’ and ‘the source’ must be clearly indicated in the text. The reproduced lines must be in italics and given within quotes. If it is a paragraph it must be slightly indented also. To reproduce large portions of text, permission from the copyright owner(s) must be obtained and submitted to Journal of Science and Technology Advances. To reproduce tables or illustrations, permission from the copyright owner(s) must be obtained and a copy of the permission letter must be submitted to the journal. The source must be clearly acknowledged below the table or illustration as required by the copyright owner(s).

Authors’ checklist for Submission

  • Registration and login are required to submit items online and to check the status of current submissions.
  • Manuscript as per Authors
  • Cover Letter
  • Copyright Transfer Form duly signed by all authors.
  • Thoroughly check the reference style as mentioned above.
  • Thoroughly check the article for correct grammar, in particular: spelling of names, affiliations, any symbols, equations, etc.
  • Provide all figures and graphics in 350 Dpi along with legend (If any)

Journal of Science and Technology Advances also provides fast track review and publication facility to reduce the decision and publication time. Please send a mail to the editor (editor@onlinepbe.com) to know more about this service.

Tutorial For Submitting a Manuscript

Indexed In


Google Scolar
Creative Commons
OJS

Follow Us


facebook twitter

Get in touch


editor@imedpharm.com
+91-701  913  9881
+91-7019139881
editor@imedpharm.com
© Copyright 2017. All Rights Reserved.  By iMedPharm